PAR PHARM INC FDA Approval NDA 018024

NDA 018024

PAR PHARM INC

FDA Drug Application

Application #018024

Documents

Letter2003-05-30
Letter2005-08-31
Review2007-08-06
Label2005-08-31
Review2007-07-18
Letter2016-12-19
Label2016-12-21
Label2019-10-07
Letter2019-10-08

Application Sponsors

NDA 018024PAR PHARM INC

Marketing Status

Discontinued001
Discontinued002

Application Products

001INJECTABLE;INJECTION10MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**1NUBAINNALBUPHINE HYDROCHLORIDE
002INJECTABLE;INJECTION20MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**1NUBAINNALBUPHINE HYDROCHLORIDE

FDA Submissions

TYPE 1; Type 1 - New Molecular EntityORIG1AP1979-05-15STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL2AP1980-01-24STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL3AP1980-02-21STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL6AP1981-02-20STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL7AP1981-04-01STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL10AP1982-05-27STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL11AP1982-05-27STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL12AP1982-05-20STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL13AP1982-05-20STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL14AP1984-03-02STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL15AP1984-03-02STANDARD
EFFICACY; EfficacySUPPL16AP1986-10-23
LABELING; LabelingSUPPL17AP1983-02-16
MANUF (CMC); Manufacturing (CMC)SUPPL18AP1983-08-17STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL19AP1983-08-17STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL20AP1984-09-17STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL21AP1984-09-13STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL22AP1984-09-13STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL23AP1984-11-28STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL24AP1988-03-03STANDARD
LABELING; LabelingSUPPL26AP1987-08-04
LABELING; LabelingSUPPL27AP1988-11-10
MANUF (CMC); Manufacturing (CMC)SUPPL28AP1987-12-07STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL29AP1988-11-10STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL31AP1990-10-19STANDARD
LABELING; LabelingSUPPL32AP1994-11-02
MANUF (CMC); Manufacturing (CMC)SUPPL33AP1993-10-15STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL35AP1995-12-15STANDARD
LABELING; LabelingSUPPL36AP2003-04-30STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL37AP2002-04-16STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL38AP2002-01-15STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL39AP2002-10-25STANDARD
LABELING; LabelingSUPPL40AP2005-08-23STANDARD
LABELING; LabelingSUPPL41AP2016-12-16STANDARD
LABELING; LabelingSUPPL42AP2019-10-07STANDARD

Submissions Property Types

SUPPL2Null0
SUPPL3Null0
SUPPL6Null0
SUPPL7Null0
SUPPL10Null0
SUPPL11Null0
SUPPL12Null0
SUPPL13Null0
SUPPL14Null0
SUPPL15Null0
SUPPL18Null0
SUPPL19Null0
SUPPL20Null0
SUPPL21Null0
SUPPL22Null0
SUPPL23Null0
SUPPL24Null0
SUPPL28Null0
SUPPL29Null0
SUPPL31Null0
SUPPL33Null0
SUPPL35Null0
SUPPL37Null0
SUPPL38Null0
SUPPL39Null0
SUPPL41Null7
SUPPL42Null15

CDER Filings

PAR PHARM INC
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 18024
            [companyName] => PAR PHARM INC
            [docInserts] => ["",""]
            [products] => [{"drugName":"NUBAIN","activeIngredients":"NALBUPHINE HYDROCHLORIDE","strength":"10MG\/ML **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**","dosageForm":"INJECTABLE;INJECTION","marketingStatus":"Discontinued","te":"None","rld":"Yes","rs":"No"},{"drugName":"NUBAIN","activeIngredients":"NALBUPHINE HYDROCHLORIDE","strength":"20MG\/ML **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**","dosageForm":"INJECTABLE;INJECTION","marketingStatus":"Discontinued","te":"None","rld":"Yes","rs":"No"}]
            [labels] => [{"actionDate":"10\/07\/2019","submission":"SUPPL-42","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2019\\\/018024s042lbl.pdf\"}]","notes":""},{"actionDate":"12\/16\/2016","submission":"SUPPL-41","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2016\\\/018024s041lbl.pdf\"}]","notes":""},{"actionDate":"08\/23\/2005","submission":"SUPPL-40","supplementCategories":"Labeling","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2005\\\/018024s040lbl.pdf\"}]","notes":""}]
            [originalApprovals] => [{"actionDate":"NUBAIN","submission":"NALBUPHINE HYDROCHLORIDE","actionType":"10MG\/ML **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**","submissionClassification":"INJECTABLE;INJECTION","reviewPriority":"Discontinued","inserts":"[]","notes":">Yes"},{"actionDate":"NUBAIN","submission":"NALBUPHINE HYDROCHLORIDE","actionType":"20MG\/ML **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**","submissionClassification":"INJECTABLE;INJECTION","reviewPriority":"Discontinued","inserts":"[]","notes":">Yes"}]
            [supplements] => 
            [actionDate] => 2019-10-07
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.